Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Disc Medicine Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Disc Medicine Inc. June 11, 202597.0%
-
Disc Medicine Inc. June 9, 202399.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Indivior Pharmaceuticals Inc. | Other | +42,009 | — | — |
| Nov 2, 2026 | Supernus Pharmaceuticals Inc. | Other | −27,277 | — | — |
| Mar 6, 2026 | Supernus Pharmaceuticals Inc. | Option exercise | +7,905 | $25.30 | $199,997 |
| Mar 6, 2026 | Supernus Pharmaceuticals Inc. | Open-market sale | −8,787 | $53.00 | $465,711 |
| Mar 5, 2026 | Supernus Pharmaceuticals Inc. | Open-market sale | −10,000 | $53.71 | $537,100 |
| Feb 24, 2026 | Supernus Pharmaceuticals Inc. | Grant or award | +4,475 | — | — |
| Feb 23, 2026 | Supernus Pharmaceuticals Inc. | Option exercise | +15,000 | $12.98 | $194,700 |
| Feb 22, 2025 | Supernus Pharmaceuticals Inc. | Grant or award | +5,369 | — | — |
| Nov 8, 2024 | Supernus Pharmaceuticals Inc. | Option exercise | +10,787 | $11.46 | $123,619 |
| Nov 8, 2024 | Supernus Pharmaceuticals Inc. | Open-market sale | −10,787 | $36.30 | $391,568 |
| Nov 7, 2024 | Supernus Pharmaceuticals Inc. | Option exercise | +14,213 | $11.46 | $162,881 |
| Nov 7, 2024 | Supernus Pharmaceuticals Inc. | Open-market sale | −14,213 | $36.62 | $520,480 |
| Sep 13, 2024 | Supernus Pharmaceuticals Inc. | Open-market sale | −3,886 | $31.33 | $121,748 |
| Sep 13, 2024 | Supernus Pharmaceuticals Inc. | Option exercise | +10,000 | $11.46 | $114,600 |
| Sep 13, 2024 | Supernus Pharmaceuticals Inc. | Open-market sale | −10,000 | $31.33 | $313,300 |
Questions about Georges Gemayel
What boards is Georges Gemayel on?
Georges Gemayel sits on the boards of Disc Medicine Inc., Indivior Pharmaceuticals Inc. and Supernus Pharmaceuticals Inc.
How long has Georges Gemayel served on boards?
Our records show at least 8 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.